loadpatents
name:-0.016592025756836
name:-0.0040240287780762
name:-0.010439872741699
Anderson; Ana Carrizosa Patent Filings

Anderson; Ana Carrizosa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anderson; Ana Carrizosa.The latest application filed is for "methods and compositions for the modulation of opioid signaling in the tumor microenvironment".

Company Profile
11.3.17
  • Anderson; Ana Carrizosa - Boston MA
  • Anderson; Ana Carrizosa - Brookline MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For The Modulation Of Opioid Signaling In The Tumor Microenvironment
App 20220105135 - Singer; Meromit ;   et al.
2022-04-07
Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1
Grant 11,186,825 - Regev , et al. November 30, 2
2021-11-30
Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3
Grant 11,180,730 - Regev , et al. November 23, 2
2021-11-23
Methods And Compositions For Modulating Suppression Of Lymphocyte Activity
App 20210130776 - Anderson; Ana Carrizosa ;   et al.
2021-05-06
Pan-cancer T Cell Exhaustion Genes
App 20210130438 - Jerby-Arnon; Livnat ;   et al.
2021-05-06
Methods And Compositions For The Modulation Of Cell Interactions And Signaling In The Tumor Microenvironment
App 20210102168 - Singer; Meromit ;   et al.
2021-04-08
Methods And Compositions For Enhancing Anti-tumor Immunity By Targeting Steroidogenesis
App 20210100774 - Anderson; Ana Carrizosa ;   et al.
2021-04-08
Methods For Predicting Outcomes And Treating Colorectal Cancer Using A Cell Atlas
App 20210047694 - Regev; Aviv ;   et al.
2021-02-18
T cell balance gene expression, compositions of matters and methods of use thereof
Grant 10,822,587 - Regev , et al. November 3, 2
2020-11-03
Compositions And Methods Targeting Complement Component 3 For Inhibiting Tumor Growth
App 20200102386 - Regev; Aviv ;   et al.
2020-04-02
Compositions And Methods Targeting Complement Component 3 For Inhibiting Tumor Growth
App 20200023007 - Regev; Aviv ;   et al.
2020-01-23
Modulation Of Novel Immune Checkpoint Targets
App 20200016202 - KUCHROO; Vijay K. ;   et al.
2020-01-16
Methods And Compositions Targeting Glucocorticoid And Il-27 Signaling For Modulating Immune Responses
App 20190365781 - Anderson; Ana Carrizosa ;   et al.
2019-12-05
Compositions And Methods For Evaluating And Modulating Immune Responses By Detecting And Targeting Pou2af1
App 20190106678 - Regev; Aviv ;   et al.
2019-04-11
Compositions And Methods For Evaluating And Modulating Immune Responses By Detecting And Targeting Gata3
App 20190106679 - Regev; Aviv ;   et al.
2019-04-11
Compositions And Methods For Evaluating And Modulating Immune Responses By Use Of Immune Cell Gene Signatures
App 20190100801 - Regev; Aviv ;   et al.
2019-04-04
Methods For Modulating Immune Responses During Chronic Immune Conditions By Targeting Il-27 Induced Pathways
App 20170058026 - Kuchroo; Vijay K. ;   et al.
2017-03-02
T Cell Balance Gene Expression, Compositions Of Matters And Methods Of Use Thereof
App 20150361396 - Regev; Aviv ;   et al.
2015-12-17
Methods For Modulating Immune Responses During Chronic Immune Conditions By Targeting Il-27 Induced Pathways
App 20150284459 - Kuchroo; Vijay K. ;   et al.
2015-10-08
Methods For Modulating A Population Of Myeloid-derived Suppressor Cells And Uses Thereof
App 20110059106 - Kuchroo; Vijay K. ;   et al.
2011-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed